Synta Pharmaceuticals Corp $4.39

down 0.00


22/4/2014 08:10 PM  |  NASDAQ : SNTA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get SNTA Trend Analysis - it has underperformed the S&P 500 by 73%

Partner Headlines

  1. Morning Market Movers

    Benzinga
  2. Benzinga's Top #PreMarket Gainers

    Benzinga
  3. Top Trending Tickers On StockTwits For March 12

    Benzinga
  4. Morning Movers for March 12th, 2014

    Benzinga
  5. Morning Market Losers

    Benzinga
  6. Benzinga's Top #PreMarket Losers

    Benzinga
  7. UPDATE: Stifel Downgrades Synta Pharmaceuticals as GALAXY-2 Adjustments ...

    Benzinga
  8. Earnings Scheduled For March 11, 2014

    Benzinga
  9. Stocks Hitting 52-Week Lows

    Benzinga
  10. Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock ...

    Benzinga
  11. Synta Presents Positive One-Year Follow-up Results for GALAXY-1 Trial of ...

    Benzinga
  12. Synta Announces Encouraging Results of Ganetespib GALAXY-1 Trial at ECC ...

    Benzinga
  13. Shares of Synta Moving Higher Following News of Fast Track Designation ...

    Benzinga
  14. These Three Speculative Companies Are Loved By Insiders and Institutions

    Benzinga
  15. Synta Provides Clinical Updates

    Benzinga
  16. Synta Provides Clinical Updates

    Benzinga
  17. Market Wrap for Monday, July 29: Stocks Record Moderate Losses to Start ...

    Benzinga
  18. Synta Pharmaceuticals Surges 45% on Positive ENCHANT-1 Breast Cancer Results

    Benzinga
  19. Synta Announces ENCHANT-1 Breast Cancer Results Support Transition to Second ...

    Benzinga
  20. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus
  21. Synta Pharmaceuticals, Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus
  22. Synta Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  23. UPDATE: Jefferies Raises PT to $22 on Synta Pharmaceuticals on GALAXY Update

    Benzinga
  24. UPDATE: Stifel Nicolaus Initiates Synta Pharmaceuticals at Hold; Enthusiasm ...

    Benzinga
  25. Synta Announces $25.8 Million Registered Direct Offering of Common Stock

    Benzinga
  26. Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI

    GuruFocus
  27. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus
  28. Health Care Sector Wrap

    FoxBusiness
  29. Synta Pharmaceuticals (SNTA) Up 15% after Jefferies Issues Bullish Note

    MarketIntelligenceCenter
  30. UPDATE: Jefferies Raises PT on Synta from $7 to $14

    Benzinga
  31. Teva Pharmaceutical Industries, Constellation Brands Among Stocks Up on ...

    FoxBusiness
  32. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs Monday

    FoxBusiness
  33. Merck &, Onyx Pharmaceuticals Among Stocks Hitting 52-Week Highs Friday

    FoxBusiness
  34. UPDATE: BMO Capital Markets Upgrades Synta Pharmaceuticals to Outperform ...

    Benzinga
  35. Benzinga's Top Pre-Market Losers

    Benzinga
  36. Today's Top Small-Cap Winners!

    Benzinga
  37. UPDATE: Jefferies Initiates Coverage on Synta Pharmaceuticals

    Benzinga
  38. Synta Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus
  39. Earnings Scheduled For February 22

    Benzinga
  40. These 4 Biotech Stocks Are a Buy Now

    GuruFocus
  41. Notable Put Options Activity in Synta Pharmaceuticals

    Benzinga
  42. UPDATE: Synta Prices 7M Shares at $4.40 Each

    Benzinga
  43. McNicoll Lewis & Vlak Reiterates Buy, $10 Target on Synta Pharmaceuticals

    Benzinga
Trading Center